HAE
Haemonetics CorporationNYSEHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$2.79B
P/E Ratio
16.41
EPS
$3.63
Beta
0.36
52W High
$87.32
52W Low
$47.32
50-Day MA
$61.13
200-Day MA
$64.94
Dividend Yield
—
Profit Margin
13.30%
Forward P/E
10.43
PEG Ratio
0.87
About Haemonetics Corporation
Haemonetics Corporation, a healthcare company, offers medical products and solutions. The company is headquartered in Boston, Massachusetts.
Fundamentals
| Revenue (TTM) | $1.32B |
| Gross Profit (TTM) | $793.78M |
| EBITDA | $364.90M |
| Operating Margin | 21.00% |
| Return on Equity | 19.30% |
| Return on Assets | 6.45% |
| Revenue/Share (TTM) | $27.51 |
| Book Value | $19.46 |
| Price-to-Book | 2.90 |
| Price-to-Sales (TTM) | 2.12 |
| EV/Revenue | 2.657 |
| EV/EBITDA | 9.63 |
| Quarterly Earnings Growth (YoY) | 28.40% |
| Quarterly Revenue Growth (YoY) | -2.70% |
| Shares Outstanding | $46.47M |
| Float | $45.92M |
| % Insiders | 1.19% |
| % Institutions | 115.29% |
Analyst Ratings
Consensus ($87.50 target)
4
Strong Buy3
Buy4
HoldData last updated: 4/8/2026